RARE vs VNO · rev $350.0M vs rev $921.3M
Ultragenyx (RARE) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
RARE currently screens at market cap $2.79B. VNO currently screens at market cap $0.
Not investment advice. Open the RARE and VNO stock pages for the full models.
Not investment advice.